Advanced Breast Cancer Therapies
Advanced Breast Cancer Therapies is a topic indexed in ScholarIQ from OpenAlex.
What is known about Advanced Breast Cancer Therapies?
This cluster of papers focuses on the use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as palbociclib, letrozole, ribociclib, and abemaciclib, in the treatment of hormone receptor-positive metastatic breast cancer. The papers cover various aspects including clinical trials, mechanisms of action, therapeutic resistance, combination strategies, and potential biomarkers.
How many works does Advanced Breast Cancer Therapies have?
Advanced Breast Cancer Therapies has 36,060 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Advanced Breast Cancer Therapies have?
Advanced Breast Cancer Therapies has 247,419 citations in the OpenAlex counts ScholarIQ stores.
What is the OpenAlex record for Advanced Breast Cancer Therapies?
The OpenAlex for Advanced Breast Cancer Therapies is on the source record.